Abstract
To compare plasma lysophosphatidic acid (LPA) level in ovarian cancer patients and women without ovarian pathology. Plasma LPA levels were elevated in ovarian cancer patients.
Lysophosphatidic acid appears useful as diagnostic marker of ovarian cancer.